Oscar Health Inc (NYSE:OSCR) is in desperate need of a sentiment reversal, with the underlying equity bleeding market value recently. In the trailing five sessions, OSCR stock slipped 15%, while in the past month, it lost more than 31%. With skepticism seemingly mounting from all angles, the healthcare tech company — which specializes in the insurance segment — appears woefully treacherous. Still, hidden beneath the red ink could lie an opportunity for extreme contrarians.
On the surface, circumstances really don't look pleasant, with the bullish case possibly easy to dismiss as irrational. In the company's recent third-quarter disclosure, Oscar posted a loss of 53 cents per share, which mitigated the expected loss of 57 cents per share. However, revenue of $2.99 billion missed expectations, which called for $3.09 billion.
